537 related articles for article (PubMed ID: 21830966)
1. Intrapleural use of tissue plasminogen activator and DNase in pleural infection.
Rahman NM; Maskell NA; West A; Teoh R; Arnold A; Mackinlay C; Peckham D; Davies CW; Ali N; Kinnear W; Bentley A; Kahan BC; Wrightson JM; Davies HE; Hooper CE; Lee YC; Hedley EL; Crosthwaite N; Choo L; Helm EJ; Gleeson FV; Nunn AJ; Davies RJ
N Engl J Med; 2011 Aug; 365(6):518-26. PubMed ID: 21830966
[TBL] [Abstract][Full Text] [Related]
2. New strategies to manage complicated pleural effusions.
Safiyeh M; Huang D
Crit Care; 2012 May; 16(3):312. PubMed ID: 22621656
[TBL] [Abstract][Full Text] [Related]
3. Modified regimen intrapleural alteplase with pulmozyme in pleural infection management: a tertiary teaching hospital experience.
Cheong XK; Ban AY; Ng BH; Nik Abeed NN; Nik Ismail NA; Nik Fuad NF; Syed Zakaria SZ; Ghan SL; Abdul Hamid MF
BMC Pulm Med; 2022 May; 22(1):199. PubMed ID: 35581627
[TBL] [Abstract][Full Text] [Related]
4. Intrapleural agents for pleural infection: fibrinolytics and beyond.
Rahman NM
Curr Opin Pulm Med; 2012 Jul; 18(4):326-32. PubMed ID: 22487944
[TBL] [Abstract][Full Text] [Related]
5. Effectiveness of Intrapleural Tissue Plasminogen Activator and Dornase Alfa vs Tissue Plasminogen Activator Alone in Children with Pleural Empyema: A Randomized Clinical Trial.
Livingston MH; Mahant S; Connolly B; MacLusky I; Laberge S; Giglia L; Yang C; Roberts A; Shawyer A; Brindle M; Parsons S; Stoian C; Walton JM; Thorpe KE; Chen Y; Zuo F; Mamdani M; Chan C; Loong D; Isaranuwatchai W; Ratjen F; Cohen E
JAMA Pediatr; 2020 Apr; 174(4):332-340. PubMed ID: 32011642
[TBL] [Abstract][Full Text] [Related]
6. Intrapleural tissue plasminogen activator and deoxyribonuclease for pleural infection. An effective and safe alternative to surgery.
Piccolo F; Pitman N; Bhatnagar R; Popowicz N; Smith NA; Brockway B; Nickels R; Burke AJ; Wong CA; McCartney R; Choo-Kang B; Blyth KG; Maskell NA; Lee YC
Ann Am Thorac Soc; 2014 Nov; 11(9):1419-25. PubMed ID: 25296241
[TBL] [Abstract][Full Text] [Related]
7. U.K. Controlled trial of intrapleural streptokinase for pleural infection.
Maskell NA; Davies CW; Nunn AJ; Hedley EL; Gleeson FV; Miller R; Gabe R; Rees GL; Peto TE; Woodhead MA; Lane DJ; Darbyshire JH; Davies RJ;
N Engl J Med; 2005 Mar; 352(9):865-74. PubMed ID: 15745977
[TBL] [Abstract][Full Text] [Related]
8. Concurrent Versus Sequential Intrapleural Instillation of Tissue Plasminogen Activator and Deoxyribonuclease for Pleural Infection.
Kheir F; Cheng G; Rivera E; Folch A; Folch E; Fernandez-Bussy S; Keyes C; Parikh M; Channick C; Chee A; Majid A
J Bronchology Interv Pulmonol; 2018 Apr; 25(2):125-131. PubMed ID: 29346247
[TBL] [Abstract][Full Text] [Related]
9. Intrapleural tissue plasminogen activator and deoxyribonuclease administered concurrently and once daily for complex parapneumonic pleural effusion and empyema.
Smith D; Shaw H; Ryder T
Intern Med J; 2023 Dec; 53(12):2313-2318. PubMed ID: 37029951
[TBL] [Abstract][Full Text] [Related]
10. Cost-effectiveness of intrapleural use of tissue plasminogen activator and DNase in pleural infection: evidence from the MIST2 randomised controlled trial.
Luengo-Fernandez R; Penz E; Dobson M; Psallidas I; Nunn AJ; Maskell NA; Rahman NM
Eur Respir J; 2019 Aug; 54(2):. PubMed ID: 31097519
[TBL] [Abstract][Full Text] [Related]
11. Concurrent Intrapleural Instillation of Tissue Plasminogen Activator and DNase for Pleural Infection. A Single-Center Experience.
Majid A; Kheir F; Folch A; Fernandez-Bussy S; Chatterji S; Maskey A; Fashjian M; Cheng G; Ochoa S; Alape D; Folch E
Ann Am Thorac Soc; 2016 Sep; 13(9):1512-8. PubMed ID: 27333122
[TBL] [Abstract][Full Text] [Related]
12. Alteplase Dose Assessment for Pleural infection Therapy (ADAPT) Study-2: Use of 2.5 mg alteplase as a starting intrapleural dose.
Popowicz N; Ip H; Lau EPM; Piccolo F; Dootson K; Yeoh C; Phu WY; Brown R; West A; Ahmed L; Lee YCG
Respirology; 2022 Jul; 27(7):510-516. PubMed ID: 35441458
[TBL] [Abstract][Full Text] [Related]
13. Intra-pleural fibrinolytic therapy versus placebo, or a different fibrinolytic agent, in the treatment of adult parapneumonic effusions and empyema.
Altmann ES; Crossingham I; Wilson S; Davies HR
Cochrane Database Syst Rev; 2019 Oct; 2019(10):. PubMed ID: 31684683
[TBL] [Abstract][Full Text] [Related]
14. Intrapleural Fibrinolytics and Deoxyribonuclease for Treatment of Indwelling Pleural Catheter-Related Pleural Infection: A Multi-Center Observational Study.
Fitzgerald DB; Muruganandan S; Tsim S; Ip H; Asciak R; Walker S; Uribe Becerra JP; Majid A; Ahmed L; Rahman NM; Maskell NA; Blyth KG; Lee YCG
Respiration; 2021; 100(5):452-460. PubMed ID: 33784710
[TBL] [Abstract][Full Text] [Related]
15. The first use of combination of Intrapleural Fibrinolytics (Alteplase & DNAse) for pleural infection in Malaysia.
Muhammad Redzwan SRA
Med J Malaysia; 2019 Apr; 74(2):176-178. PubMed ID: 31079131
[TBL] [Abstract][Full Text] [Related]
16. Safety and Efficacy of Tissue Plasminogen Activator and DNase for Complicated Pleural Effusions Secondary to Abdominal Pathology.
Majid A; Ochoa S; Chatterji S; Fernandez-Bussy S; Kheir F; Rivera E; Cheng G; Folch E
Ann Am Thorac Soc; 2017 Mar; 14(3):342-346. PubMed ID: 28079399
[TBL] [Abstract][Full Text] [Related]
17. Biological effect of tissue plasminogen activator (t-PA) and DNase intrapleural delivery in pleural infection patients.
Kanellakis NI; Wrightson JM; Hallifax R; Bedawi EO; Mercer R; Hassan M; Asciak R; Hedley E; Dobson M; Dong T; Psallidas I; Rahman NM
BMJ Open Respir Res; 2019; 6(1):e000440. PubMed ID: 31673364
[TBL] [Abstract][Full Text] [Related]
18. Predictive Variables for Failure in Administration of Intrapleural Tissue Plasminogen Activator/Deoxyribonuclease in Patients With Complicated Parapneumonic Effusions/Empyema.
Khemasuwan D; Sorensen J; Griffin DC
Chest; 2018 Sep; 154(3):550-556. PubMed ID: 29425674
[TBL] [Abstract][Full Text] [Related]
19. Management of Intrapleural Sepsis with Once Daily Use of Tissue Plasminogen Activator and Deoxyribonuclease.
Mehta HJ; Biswas A; Penley AM; Cope J; Barnes M; Jantz MA
Respiration; 2016; 91(2):101-6. PubMed ID: 26761711
[TBL] [Abstract][Full Text] [Related]
20. Comparing the outcomes of intrapleural fibrinolytic and DNase therapy versus intrapleural fibrinolytic or DNase therapy: A systematic review and meta-analysis.
Chong WH; Hu K; Saha BK; Chopra A
Pulm Pharmacol Ther; 2021 Dec; 71():102081. PubMed ID: 34571093
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
